WEBULL
News
SDGR
13.60
+0.82%
0.11
Weekly Report: what happened at SDGR last week (0202-0206)?
Weekly Report · 20h ago
With A 26% Price Drop For Schrödinger, Inc. (NASDAQ:SDGR) You'll Still Get What You Pay For
Simply Wall St · 5d ago
OpenAI considers backing AI-led drug discovery firms: report
Seeking Alpha · 6d ago
Analysts Are Bullish on Top Healthcare Stocks: Spectral AI (MDAI), Schrodinger (SDGR)
TipRanks · 02/02 14:31
Weekly Report: what happened at SDGR last week (0126-0130)?
Weekly Report · 02/02 09:44
Assessing Schrödinger (SDGR) Valuation As Its Computational Platform And Novartis Collaboration Draw Fresh Attention
Simply Wall St · 01/31 04:39
Private Markets: Nvidia, Microsoft consider new investment in OpenAI
TipRanks · 01/30 15:51
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Spectral AI (MDAI) and Schrodinger (SDGR)
TipRanks · 01/27 13:20
Weekly Report: what happened at SDGR last week (0119-0123)?
Weekly Report · 01/26 09:45
Is Manas AI’s Platform Deal Reshaping the Investment Case For Schrödinger’s (SDGR) Drug Discovery Model?
Simply Wall St · 01/25 00:31
Schrödinger (SDGR) Valuation Check As New AI Partnerships With Manas AI And Eli Lilly Take Shape
Simply Wall St · 01/23 22:31
Weekly Report: what happened at SDGR last week (0112-0116)?
Weekly Report · 01/19 09:48
Assessing Schrödinger (SDGR) Valuation As Shares Trade Near US$18 Despite Mixed Return Profile
Simply Wall St · 01/14 04:51
Schrödinger Reports 2025 Progress, Highlights Physics+AI Platform Growth, Strategic Collaborations And Proprietary Therapeutics; Outlines 2026 Priorities For Platform Scaling And Clinical Advancements
Benzinga · 01/12 13:40
Schrödinger Inc. Outlines 2026 Strategic Priorities to Scale Impact, Expand Platform Reach, Advance Collaborative Drug Discovery, and Secure Development Partners
Reuters · 01/12 13:31
SCHRÖDINGER PROVIDES UPDATE ON PROGRESS ACROSS THE BUSINESS AND OUTLINES 2026 STRATEGIC PRIORITIES
Reuters · 01/12 13:30
Weekly Report: what happened at SDGR last week (0105-0109)?
Weekly Report · 01/12 09:47
Is Schrödinger’s TuneLab AI Integration Reshaping the Investment Case For SDGR?
Simply Wall St · 01/09 15:35
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Schrodinger (SDGR)
TipRanks · 01/09 14:30
Eli Lilly in pact with Schrödinger, Revvity for AI-driven drug discovery
Seeking Alpha · 01/09 14:15
More
Webull provides a variety of real-time SDGR stock news. You can receive the latest news about Schrodinger, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About SDGR
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Its segments include Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in the material science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor), and others. Its software has been used by researchers around the world at more than 1,818 academic institutions.